Avere Therapeutics raises $500M in private placement for drug program Aug 10, 2026 07:01AM
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 Aug 10, 2026 07:00AM